Default company panoramic image
A9b60657 7a13 41b9 8056 0182621f3299

Amiracool Medical

Amiracool has a device for the care of tracheostomy patients. The "TrachNeb" automatically removes secretions from a patient's airway.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location St. Louis, MO, USA
  • Currency USD
  • Founded February 2011
  • Employees 3
  • Website

Company Summary

The TrachNeb device automates a procedure that has remained unchanged for decades - the manual suctioning of tracheostomy patients. The Amiracool device will provide material savings, labor savings, and improve patient care, relieving caregivers of this burden (and an unpleasant task). The TrachNeb can be configured for hospitals, LTACs, Nursing Homes, or for in-home care.


  • Default avatar
    Dennis M Plummer
    President and CEO

    Dennis had 28 years at Monsanto (1980 to 2009); with numerous commercial and general management roles including head of the US business; lead for global biotechnology introductions; President of American Seeds division; and chief of staff to last two Monsanto CEOs. He has experience in corporate strategy and acquisitions/mergers. Since leaving Monsanto 3.5 years ago Dennis has done strategic consulting and participated in two start-ups.

  • Default avatar
    Rick Shore
    Chief Technology Office

    President and Owner of Bemes Home Medical Company. Rick was the founder of Bemes Home Medical over 8 years ago which has become one of the major home medical equipment companies in the St. Louis area for managing respiratory patients in the home. Prior to Bemes, Rick worked in the respiratory care industry for over 25 years including many years with Respironics, Inc., and Ohmeda. Rick has unmatched experience in respiratory care systems, has ma

  • Default avatar
    Grant Bochicchio

    MD, MPH, FACS; Edison Professor of Surgery – Chief of Acute and Critical Care Surgery, Washington University School of Medicine. Dr. Bochicchio was recently recruited as the for the Chief of ACCS position at Washington University in St. Louis. This role encompasses trauma, surgical critical care, emergency surgery, burns and advanced wound therapy. Dr. Bochicchio received his critical care training at the world famous R Adams Cowley Shock Traum

  • Default avatar
    David Cool

    Inventor of the TrachNeb, using experience in electronic engineering, has designed and developed a life saving device currently in operation on his mother Loretta. David under the supervision of his father began repairing equipment when he was just 10 years old. David was an aircraft pilot with a lifetime in the field of electronics, with a particular specialization in aircraft navigation systems and the design, repair and computer integration of

  • Default avatar
    Andy Winslow

    PhD Engineering Mechanics from the University of Florida, MS Physics, University of Missouri, BA Mathematics, University of Missouri. Andy designs and writes all software/code for the TrachNeb. Andy has 17 yrs experience designing data acquisition and control systems using National Instruments hardware and software. He is also a certified NI LabView architect. Andy has designed the National Instruments hardware and software system currently o

  • Default avatar
    Kelly Bochicchio

    RN, MS; Senior Research Administrator, Washington University School of Medicine in St. Louis. Kelly received her Bachelors and Masters degrees from the University of Maryland, School of Nursing and was the Research Manager for the Division of Clinical and Outcomes Research at the R Adams Cowley Shock Trauma Center prior to coming to St. Louis to assume the role as Senior Research Administrator at Washington University in St. Louis. Kelly works c


  • Default avatar
    Lewis & Rice; Wittner Spewak; Polsinelli
    Default avatar
    Tax Strategies

Previous Investors

  • Default avatar
    Cool and Miranda family LLCs - approx 92% owners
    Default avatar
    7 friends - approx 5.6%
    Default avatar
    Dennis Plummer 2.25% (plus incentive/contingent add'l 4.5%)